Cargando…

The ether lipid tumour marker in human liver with hepatocellular carcinoma.

Detalles Bibliográficos
Autores principales:	Lin, H. J., Wu, P. C., Ho, J. C.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1980
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010194/ https://www.ncbi.nlm.nih.gov/pubmed/6245673

Ejemplares similares

Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma.
por: Tsai, J. F., et al.
Publicado: (1995)

Difference in tissue expression of tumour markers CA 19-9 and CA 50 in hepatocellular carcinoma and cholangiocarcinoma.
por: Haglund, C., et al.
Publicado: (1991)

Tumour scanning with indium-111 dihaematoporphyrin ether.
por: Quastel, M. R., et al.
Publicado: (1990)

Clinical evaluation of urinary transforming growth factor-beta1 and serum alpha-fetoprotein as tumour markers of hepatocellular carcinoma.
por: Tsai, J. F., et al.
Publicado: (1997)

Exceptional human longevity is associated with a specific plasma phenotype of ether lipids
por: Pradas, I., et al.
Publicado: (2019)

Overexpression of hepatic prothymosin alpha, a novel marker for human hepatocellular carcinoma.
por: Wu, C. G., et al.
Publicado: (1997)

Growth arrest vs direct cytotoxicity and the importance of molecular structure for the in vitro anti-tumour activity of ether lipids.
por: Lohmeyer, M., et al.
Publicado: (1995)

Aberrant Lipid Metabolism in Hepatocellular Carcinoma Revealed by Liver Lipidomics
por: Li, Zhao, et al.
Publicado: (2017)

Associating transcriptomics data with inflammatory markers to understand tumour microenvironment in hepatocellular carcinoma
por: Bahcivanci, Basak, et al.
Publicado: (2022)

Hepatitis-B surface antigen in tumour tissue and non-tumorous liver in black patients with hepatocellular carcinoma.
por: Kew, M. C., et al.
Publicado: (1980)

Structural and functional roles of ether lipids
por: Dean, John M., et al.
Publicado: (2017)

Elevated urinary transforming growth factor-beta1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma.
por: Tsai, J. F., et al.
Publicado: (1997)

Biosynthesis of archaeal membrane ether lipids
por: Jain, Samta, et al.
Publicado: (2014)

Ether lipid deficiency disrupts lipid homeostasis leading to ferroptosis sensitivity
por: Perez, Marcos A., et al.
Publicado: (2022)

Ether Lipids in Obesity: From Cells to Population Studies
por: Schooneveldt, Yvette L., et al.
Publicado: (2022)

Clinical outcome of hepatocellular carcinoma can be predicted by the expression of hepatic progenitor cell markers and serum tumour markers
por: Seino, Satoshi, et al.
Publicado: (2018)

Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells
por: Mou, D-C, et al.
Publicado: (2002)

Profiling of tumour-associated microbiota in human hepatocellular carcinoma
por: Komiyama, Seiga, et al.
Publicado: (2021)

Liver Lipids of Patients with Hepatitis B and C and Associated Hepatocellular Carcinoma
por: Haberl, Elisabeth M., et al.
Publicado: (2021)

Exogenous Ether Lipids Predominantly Target Mitochondria
por: Kuerschner, Lars, et al.
Publicado: (2012)

Orphan enzymes in ether lipid metabolism
por: Watschinger, Katrin, et al.
Publicado: (2013)

Ether lipids and a peroxisomal riddle in sperm
por: Horta Remedios, Mayrene, et al.
Publicado: (2023)

Prediction of Post-Operative Liver Dysfunction by Serum Markers of Liver Fibrosis in Hepatocellular Carcinoma
por: Shen, Yinghao, et al.
Publicado: (2015)

Identification and analysis of tumour-associated antigens in hepatocellular carcinoma
por: Shi, Y-Y, et al.
Publicado: (2005)

Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and markers of inflammation
por: Kirkham, Bruce W, et al.
Publicado: (2014)

Exosomal lipid composition and the role of ether lipids and phosphoinositides in exosome biology
por: Skotland, Tore, et al.
Publicado: (2019)

Surgical techniques and strategies for the treatment of primary liver tumours: hepatocellular and cholangiocellular carcinoma
por: Braunwarth, Eva, et al.
Publicado: (2018)

A nomogram based on combining systemic and hepatic inflammation markers for predicting microscopic bile duct tumour thrombus in hepatocellular carcinoma
por: Wu, Jun-Yi, et al.
Publicado: (2021)

Absorption of some glycol ethers through human skin in vitro.
por: Dugard, P H, et al.
Publicado: (1984)

Tumour budding and tumour–stroma ratio in hepatocellular carcinoma
por: Kairaluoma, Valtteri, et al.
Publicado: (2020)

Hepatocellular Carcinomas in Cirrhotic and Noncirrhotic Human Livers Share Angiogenic Characteristics
por: Zeng, Wenjiao, et al.
Publicado: (2010)

A Caenorhabditis elegans model for ether lipid biosynthesis and function
por: Shi, Xun, et al.
Publicado: (2016)

Comparative values of several tumour markers: example of untreated breast carcinoma.
por: Cazin, J. L., et al.
Publicado: (1990)

Remodeling Lipids in the Transition from Chronic Liver Disease to Hepatocellular Carcinoma
por: Ismail, Israa T., et al.
Publicado: (2020)

Ether with Cod Liver Oil
Publicado: (1879)

Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour
por: Johnson, P J, et al.
Publicado: (1999)

Bioactive Ether Lipids: Primordial Modulators of Cellular Signaling
por: Rangholia, Nikhil, et al.
Publicado: (2021)

Diploid nature of hepatocellular tumours developing from transplanted preneoplastic liver cells.
por: Saeter, G., et al.
Publicado: (1989)

A protein-based set of reference markers for liver tissues and hepatocellular carcinoma
por: Sun, Stella, et al.
Publicado: (2009)

Utility of Inflammatory Markers in Predicting Hepatocellular Carcinoma Survival after Liver Transplantation
por: Ismael, Media N., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_g4ude83so9lemahekhir63stce